GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
336

ACHIEVE — my 18-week log, condensed into one table

Question Long Haul ×1

Confession thread, sort of.

I went from 2.5mg to 1.0mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 15 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway.

So now I have constipation I did not need and a data point I cannot interpret. Two lessons in one.

Posting it in the hope that somebody at week 58 reads it before doing the same thing.

426 up / 90 down83% upvoted9 commentsid mpuch14 Jul 2026

9 comments

8 in this archive, depth 3

best — the order this archive was captured in

u/piotr_bruun52 points·25 days ago·edited

Second this question. I have wondered about small molecule for 18 months and never seen a straight answer.

replysharereportpermalink
u/salma_almeida43 points·24 days ago

This is correct. ATTAIN data is phase 10.

replysharereportpermalink
u/joaquin_trevino13 points·24 days ago

phase 22 data is interesting, phase 24 will tell the real story

replysharereportpermalink
u/bruno_dumitru25 points·25 days ago

oral non-peptide agonist is orforglipron, no food restrictions

replysharereportpermalink
u/dilara_weiss11 points·25 days ago

the absorption problem is solved by non-peptide structure

replysharereportpermalink
u/trialwatch_theoMOD40 points·25 days ago

Flair changed to match the content. Read the sidebar before posting next time and we are square.

replysharereportpermalink
u/scam_taxonomyc/scamalerts22 points·24 days ago

cite ATTAIN/ACHIEVE arms specifically

replysharereportpermalink
u/enzo_ferrari37 points·24 days ago·edited

no cold chain means oral GLP-1, if approved

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/orforglipron

The small-molecule oral: why a non-peptide agonist escapes the absorption problems of oral semaglutide, what the ATTAIN and ACHIEVE readouts showed, and what a pill with no refrigeration requirement would do to the entire supply conversation this site is built around.

21kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/orforglipron rules
  1. Small molecule, not a peptide. Purity discussion here is a different problem.
  2. Cite ATTAIN/ACHIEVE arms specifically when quoting numbers.
  3. Availability speculation must be flaired Speculation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.